Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Marimed (TSE:MRMD)
:MRMD
MRMD Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.07 - C$0.74
Previous CloseN/A
Volume0.00
Average Volume (3M)15.11K
Market Cap
C$80.03M
Enterprise ValueC$162.38M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.60
Next Earnings
Mar 05, 2025EPS Estimate
-0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding381,306,400
10 Day Avg. Volume17,680
30 Day Avg. Volume15,105
Standard Deviation0.29
R-Squared0.07
Alpha-0.03
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.36
Price to Cash Flow (P/CF)17.80
P/FCF Ratio0.00
Enterprise Value/Market Cap2.03
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit2.46
Enterprise Value/Ebitda22.96
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
MariMed News
PremiumCompany Announcements
MariMed Inc. Reports Third Quarter 2024 Earnings
---
Options Prices
Currently, No data available
---
Ownership Overview
10.17% Insiders
0.19% Other Institutional Investors
89.61% Public Companies and Individual Investors
MRMD FAQ
What was Marimed’s price range in the past 12 months?
Marimed lowest stock price was C$0.07 and its highest was C$0.74 in the past 12 months.
What is Marimed’s market cap?
Marimed’s market cap is C$80.03M.
When is Marimed’s upcoming earnings report date?
Marimed’s upcoming earnings report date is Mar 05, 2025 which is in 13 days.
How were Marimed’s earnings last quarter?
Marimed released its earnings results on Nov 06, 2024. The company reported C$0.006 earnings per share for the quarter, beating the consensus estimate of -C$0.014 by C$0.02.
Is Marimed overvalued?
According to Wall Street analysts Marimed’s price is currently Overvalued.
Does Marimed pay dividends?
Marimed does not currently pay dividends.
What is Marimed’s EPS estimate?
Marimed’s EPS estimate is -0.01.
How many shares outstanding does Marimed have?
Marimed has 381,306,400 shares outstanding.
What happened to Marimed’s price movement after its last earnings report?
Marimed reported an EPS of C$0.006 in its last earnings report, beating expectations of -C$0.014. Following the earnings report the stock price went down -4.762%.
Which hedge fund is a major shareholder of Marimed?
Currently, no hedge funds are holding shares in TSE:MRMD
---
MariMed Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Crowd Wisdom
Negative
Last 7 Days ▼ 2.0%
Last 30 Days ▼ 0.7%
Last 30 Days ▼ 0.7%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-47.50%
12-Months-Change
Fundamentals
Return on Equity
-18.70%
Trailing 12-Months
Asset Growth
11.46%
Trailing 12-Months
Company Description
Marimed
MariMed, Inc. engages in direct owning of cannabis licenses and management of seed-to-sale operations. The company develops precision-dosed cannabis-infused products designed for specific medical conditions and related symptoms. Its products are licensed under brands of Kalm Fusion, Betty's Eddies, and Nature's Heritage, in the form of dissolvable strips, tablets, powders, microwaveable popcorn, and fruit chews. The company was founded by Robert N. Fireman and Jon Levine on January 25, 2011 and is headquartered in Norwood, MA.
---
MRMD Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presents a mixed sentiment with strong revenue growth driven by the wholesale business and strategic expansions into new markets. However, challenges such as declining retail revenue, gross margin, and adjusted EBITDA alongside higher-than-expected preopening costs due to delays suggest a balanced outlook.Read More>---
MRMD Stock 12 Month Forecast
Average Price Target
―Technical Analysis
General Cannabis
―
Curaleaf Holdings
―
Green Thumb Industries
―
Trulieve Cannabis
―
Cresco Labs
―
Best Analysts Covering MRMD
1 Year
1 Year Success Rate
0/13 ratings generated profit
1 Year Average Return
-38.32%
reiterated a buy rating 10 months ago
Copying Andrew Semple's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -38.32% per trade.
---